The notification shall be submitted to the Director General through the Institutional Biosafety Committee in the prescribed form and accompanied by the following documents:
1. An emergency response plan.
2. Specific measures for the contained use activity (regulation + IBC).
3. Such other information as may be specified by the Board.
4. Compliant with requirements of importing country (export).